Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells

Autor: Faraahi, Z., Baud'huin, M., Croucher, P.I., Eaton, C., Lawson, M.A.

Publikováno v: In Bone May 2019 122:82-92

IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling

Autor: Saidi, S., Bouri, F., Lencel, P., Duplomb, L., Baud’huin, M., Delplace, S., Leterme, D., Miellot, F., Heymann, D., Hardouin, P., Palmer, G., Magne, D.

Publikováno v: In Cytokine 2011 53(3):347-354

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model

Autor: Moukengue, B., Brown, H.K., Charrier, C., Battaglia, S., Baud'huin, M., Quillard, T., Pham, T.M., Pateras, I.S., Gorgoulis, V.G., Helleday, T., Heymann, D., Berglund, U.W., Ory, B., Lamoureux, F.

Publikováno v: EBioMedicine
EBioMedicine, 2020, 53, pp.102704. ⟨10.1016/j.ebiom.2020.102704⟩
EBioMedicine, Elsevier, 2020, 53, pp.102704. ⟨10.1016/j.ebiom.2020.102704⟩
EBioMedicine, Vol 53, Iss, Pp-(2020)

Background: Osteosarcoma (OS) is the most common primary malignant bone tumour. Unfortunately, no new treatments are approved and over the last 30 years the survival rate remains only 30% at 5 years for poor responders justifying an urgent need of ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ed3180a13c71245eb176c5b269295c64
https://www.hal.inserm.fr/inserm-02529640

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.